The NIH Just Redefined What Counts as a Clinical Trial—Here's Why It Matters for Research
The NIH reclassified basic science studies involving humans, removing them from clinical trial requirements.
AI-curated articles from trusted sources.
The NIH reclassified basic science studies involving humans, removing them from clinical trial requirements.
A groundbreaking collaboration between the VA and NIH is launching Project IN-DEPTH to understand why up to one-third of 700,000 Gulf War veterans remain sick...
A vagus nerve implant safely reduced joint damage in rheumatoid arthritis patients who failed medication.
Scientists are harmonizing neuropsychological test data across multiple studies to unlock insights that individual trials can't reveal alone.
A major new report reveals AI is transforming how researchers identify the right patients for trials and predict treatment success.
A new AI method dramatically improves how doctors detect amyloid buildup in the brain, catching early Alzheimer's changes that standard scans miss.
Over 90% of pregnant people take medications, yet fewer than 1% of clinical trials include them—leaving doctors and patients with decades-old or indirect evidence.
New precision medicine approaches target the root causes of PCOS instead of just masking symptoms—and they could transform treatment for millions of women.
From AI that outperforms cardiologists to personalized gene therapies, seven groundbreaking medical innovations are set to transform healthcare in 2026.
Behind every cancer breakthrough lies a hidden infrastructure of data systems and trial coordination that transforms lab discoveries into patient treatments.
New cancer treatments are showing remarkable results, with some therapies tripling response rates compared to standard care in late-stage trials.
The National Institutes of Health announced its first-ever strategic plan for disability health research, marking a watershed moment for a population historically overlooked by federal science funding.
The NIH is ending federal funding for research using human fetal tissue, betting on newer lab technologies to drive medical discoveries instead.
New research techniques are revolutionizing medical studies, making findings more reliable and helping doctors make better treatment decisions.
Dr. Alan Schechter's groundbreaking research at NIH led to hydroxyurea becoming a life-changing treatment for sickle cell patients worldwide.
Four groundbreaking Parkinson's trials launching in 2026 could revolutionize treatment—from gene therapy to brain-penetrating drugs.
Despite billions in research funding, only 14% of medical discoveries ever reach patients—but translational medicine is changing that.
From personalized cancer vaccines to AI-powered treatment tools, ten major breakthroughs are transforming how we fight cancer in 2026.
New bipartisan legislation aims to transform NIH funding with a startup-style approach, potentially unlocking hundreds of millions for high-risk medical breakthroughs.
Mount Sinai's new AI platform automatically matches cancer patients to clinical trials, potentially breaking down barriers that keep 93% of patients out.
After legal pressure, the National Institutes of Health (NIH) is approving hundreds of grant applications it previously rejected or shelved, potentially unlocking billions in funding for critical health research.
From revolutionary mRNA vaccines to needle-free patches, 2026 promises game-changing medical advances that could transform how we prevent and treat diseases.
Eli Lilly's breakthrough obesity drugs have made it the first pharmaceutical company to hit $1 trillion in market value, with even more powerful treatments in development.
Lab-grown brain organoids are revolutionizing how researchers study Alzheimer's, ALS, and other brain diseases by mimicking human brain tissue.
A groundbreaking HIV vaccine trial nearly ended before it started, but last-minute intervention saved what could be a game-changing medical breakthrough.
Australian researchers developed antibodies that recognize a sugar found only on bacteria, successfully clearing deadly infections in mice.
Researchers reveal how bacteria hijack viral weapons to target human cells, opening new paths for targeted drug delivery.
New UK rules will cut clinical trial approval times to just 14 days for early-stage studies, potentially getting breakthrough treatments to patients faster.
Scientists are developing treatments that turn your body into its own pharmaceutical factory, eliminating costly lab procedures.
New obesity drugs like Mounjaro show remarkable results, but strict NHS rules and high costs are creating a two-tier system where wealth determines access.
Stanford researchers created an AI model that analyzes one night's sleep to predict over 100 health conditions with up to 89% accuracy.
New genomic mapping reveals how entire networks of genes collaborate to drive complex diseases, bridging the gap between genetic clues and treatments.
From personalized gene therapies to AI-powered diagnostics, 2026 promises major medical advances that could transform how we treat cancer, heart disease, and more.
Harvard researchers tracked 100,000+ people for decades and found five simple habits can add nearly 10 disease-free years to your life.
From the first non-opioid surgical painkiller in decades to treatments that slash cholesterol by 94%, 2025's medical breakthroughs are changing lives right now.
Cleveland Clinic researchers discovered bacteria in tumors block immune response, explaining why immunotherapy fails for many cancer patients.
A groundbreaking study in Wales found people who got the shingles vaccine were 20% less likely to develop dementia over seven years.
From slowing Huntington's disease by 75% to the first successful bladder transplant, 2025 delivered game-changing medical advances.
Scientists made breakthrough discoveries in 2025, from shingles vaccines reducing dementia risk by 20% to the first male birth control pill passing safety trials.
Scientists delivered remarkable wins in 2025 despite budget cuts, creating needle-free allergy treatments and custom gene therapies.
FDA approves tofersen, the first drug to stabilize ALS progression and improve muscle function in patients with a specific genetic form.